AstraZeneca PLC Goes into Battle to Defend Crestor

LONDON, March 6 (Reuters) - Lawyers at AstraZeneca will begin the long process of defending the company's all-important cholesterol drug Crestor from generic competition in a U.S. courtroom next week.